期刊
JOURNAL OF CLINICAL MEDICINE
卷 12, 期 18, 页码 -出版社
MDPI
DOI: 10.3390/jcm12185989
关键词
chronic coronary syndromes; residual cardiovascular risk; secondary prevention; optimal medical therapy; multidisciplinary management; angina; percutaneous coronary intervention
Chronic coronary syndrome (CCS) is a clinical presentation of coronary artery disease (CAD) and is the leading cause of mortality worldwide. Despite advances in CAD treatment, patients with CCS remain at an elevated risk of residual cardiovascular events. Understanding the level and type of residual cardiovascular risk is crucial for appropriate diagnostic tests and follow-up procedures.
Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality worldwide. Recent guidelines for the management of CCS emphasize the dynamic nature of the CAD process, replacing the term stable with chronic, as this disease is never truly stable. Despite significant advances in the treatment of CAD, patients with CCS remain at an elevated risk of major cardiovascular events (MACE) due to the so-called residual cardiovascular risk. Several pathogenetic pathways (thrombotic, inflammatory, metabolic, and procedural) may distinctly contribute to the residual risk in individual patients and represent a potential target for newer preventive treatments. Identifying the level and type of residual cardiovascular risk is essential for selecting the most appropriate diagnostic tests and follow-up procedures. In addition, new management strategies and healthcare models could further support available treatments and lead to important prognostic benefits. This review aims to provide an overview of the diagnostic and therapeutic challenges in the management of patients with CCS and to promote more effective multidisciplinary care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据